Transcription of ATC/DDD classification - WHO
{{id}} {{{paragraph}}}
ATC/DDD classification WHO drug Information Vol. 29, No. 4, 2015496 ATC/DDD classificationThe Anatomical Therapeutic Chemical (ATC) classification system and the Defined Daily Dose (DDD) as a measuring unit are tools for exchanging and comparing data on drug use at international, national or local levels. The ATC/DDD system has become the gold standard for international drug utilization research. It is maintained by the WHO Collaborating Centre for drug Statistics Methodology in Oslo, Norway. Visit for more classification (temporary)The following ATC codes and DDDs were agreed at the meeting of the WHO International Working Group for drug Statistics Methodology in October or objections to the decisions from the meeting should be forwarded to the WHO Coll
497 WHO Drug Information Vol. 29, No. 4, 2015 ATC/DDD classification New ATC 5 th level codes, continued ATC level name/INN ATC code gallium (68Ga) endotreotide V09IX09inotuzumab ozogamicin L01XC26 ixekizumab L04AC13 landiolol C07AB14
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}